Drug Trials Snapshots: DAWNZERA - DAWNZERA (donidalorsen)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-dawnzera DAWNZERA is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.

Drug Trials Snapshots: HERNEXEOS - HERNEXEOS (zongertinib)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-hernexeos HERNEXEOS is a prescription drug used to treat adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain activating mutations, as detected by an FDA-approved test, and who have received prior systemic therapy.

Medical Debt In The US: Associations With Cancer Screening, Mortality, And Health Status Odysseas P. Chatzipanagiotou, Andrea Baldo, Miho Akabane, Azza Sarfraz, Areesh Mevawalla, Jasmine King, Razeen Thammachack, and Timothy M. Pawlik

https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.00869

Potential Impact of Tariffs on Active Pharmaceutical Ingredients on the Price of U.S.-Made Generic Drugs

https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxaf247/8402426?rss=1&login=false

December 2025 | Cancer Drugs, Medical Debt, Cybersecurity & More

https://www.healthaffairs.org/toc/hlthaff/44/12

ANNOUNCEMENT – AGE-FRIENDLY HEALTH

https://www.healthaffairs.org/request-for-abstracts/age-friendly-health-2025?utm_campaign=rfa&utm_medium=email&_hsenc=p2ANqtz-94FpjKdMyEtZgrHZqVCF72YVGIwcFtbjzQ_nUuyq1SaO6jaVOikgpBr2NTKDcn3T6yrl_aWQdYhTZg4bU3WTSdM5WqEw&_hsmi=395887403&utm_content=afh&utm_source=hasu

Proposed Federal Rules Target Heatlh Care For Transgender Youth (Part 2) Katie Keith

https://www.healthaffairs.org/content/forefront/proposed-federal-rules-target-heatlh-care-transgender-youth-part-2